Impact Biomedical Stock Surges 86% Following Merger Agreement Amendment Impact Biomedical's stock experienced a dramatic 86 percent surge during after-hours trading following the announcement of amended merger terms with Dr Ashley's Bio Labs. This significant price movement reflects investor enthusiasm regarding the restructured deal, which appears to offer improved conditions for shareholders compared to the original agreement. The merger represents a strategic combination designed to enhance operational capabilities and market position within the biomedical sector. Analysts suggest the amendment likely addresses previous concerns that had dampened investor confidence in the initial proposal. The substantial after-hours jump demonstrates strong market appetite for the revised transaction terms.